Managing diabetes is about more than just blood-sugar elevation; discussions about management should go beyond medication adherence to include how the disease affects a patient's life, explains Andrew Pumerantz, DO, FACP.
Managing diabetes is about more than just blood-sugar elevation; discussions about management should go beyond medication adherence to include how the disease affects a patient's life, explains Andrew Pumerantz, DO, FACP, executive director of the Western Diabetes Institute and associate professor of Internal Medicine at Western University of Health Sciences.
He adds that because diabetes itself is a personalized condition, both the physician and the patient needs to better understand how this individualization affects lifestyle management and care.
“We’re beginning to understand that the personalized nature of the condition requires a personalized approach,” Dr Pumerantz says. “I think we’re in an early learning period for that because there’s so much about diabetes, type 2 diabetes and multi morbidity, that we don’t really understand.”
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More